Scientech Research’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-629
Closed -$10.1K – 523
2023
Q4
$10.1K Buy
+629
New +$8.36K 0.01% 305

Other funds holding NRSN

Scientech Research's NRSN Position: Q1 2024 in Review

Scientech Research sold out of NeuroSense Therapeutics (NRSN) in Q1 2024, closing a stake of 629 shares — an estimated $10.1K sold.

Scientech Research first reported a position in NRSN in Q4 2023 and held it in 1 quarter. The position peaked at $10.1K in Q4 2023. 8 funds tracked by Wall St. Rank hold NRSN as of Q1 2024.

  • Scientech Research reported no remaining NeuroSense Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Scientech Research sold 629 NeuroSense Therapeutics shares in Q1 2024, an estimated $10.1K.
  • Scientech Research first reported a position in NeuroSense Therapeutics in Q4 2023 and held it in 1 quarter.
  • Scientech Research's NeuroSense Therapeutics position peaked at $10.1K in Q4 2023.
  • 8 funds tracked by Wall St. Rank held NeuroSense Therapeutics as of Q1 2024.

Based on Scientech Research's 13F filing for Q1 2024, filed 15 May 2024.